申请人:Mckerrecher Darren
公开号:US20060058353A1
公开(公告)日:2006-03-16
Compound of formula (I) wherein A is selected from pyridin-2-yl or thiazol-2-yl and R
1
, R
2
and R
3
are as described in the specification and their use in the treatment or prevention of a disease or medical conditions mediated through glucokinase.
式(I)的复合物,其中A选自于吡啶-2-基或噻唑-2-基,R1、R2和R3如说明书所述,并且它们在通过葡萄糖激酶介导的疾病或医学状况的治疗或预防中的用途。